Drug-induced acute pancreatitis in children receiving chemotherapy for acute leukemia: does propofol increase the risk?

Anesth Analg. 2009 Aug;109(2):379-81. doi: 10.1213/ane.0b013e3181ac13ed.

Abstract

Background: The use of propofol is controversial in patients with a history of acute pancreatitis or those taking drugs, including certain chemotherapeutic drugs, that are associated with pancreatitis.

Methods: To investigate this issue, we reviewed the medical records of all children who were diagnosed with pancreatitis while receiving chemotherapy for acute leukemia during a 5-year period.

Results: A temporal relationship between propofol use and development of acute pancreatitis could not be established.

Conclusion: Propofol can be considered for general anesthesia in children who are receiving chemotherapeutic drugs that are themselves associated with acute pancreatitis or those who have a history of chemotherapy-induced pancreatitis.

MeSH terms

  • Acute Disease
  • Adolescent
  • Anesthesia, General / adverse effects
  • Anesthetics, Intravenous / adverse effects*
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Child
  • Child, Preschool
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Intraoperative Complications / epidemiology
  • Leukemia / complications*
  • Leukemia / drug therapy
  • Male
  • Pancreatitis / chemically induced*
  • Pancreatitis / epidemiology*
  • Propofol / adverse effects*
  • Risk Assessment

Substances

  • Anesthetics, Intravenous
  • Antineoplastic Agents
  • Propofol